Skip to main content

Therapeutics Startups

Updated August 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,699 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,699
Total Funding
$1.4B
Avg Funding
$57.3M
Global Reach
8
countries

Top Cities for Therapeutics

Cambridge
Burlington
Vancouver
Melbourne
Leiden
Aye

Recently Funded Companies

Export
Cambridge, United States

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

$9.9M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Burlington, United States

Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.

$42.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

NanoVation Therapeutics provides technologies utilizing lipid nanoparticles for the safe and efficient delivery of nucleic acid tissues.

Nov 2024

Founder Contacts

41,000+ verified contacts

Melbourne, Australia

Montu Group is a leading medical cannabis company with operations in Europe and Asia-Pacific.

$3.5M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands

Imuno develops a structure-based discovery engine to identify cancer-specific epitopes.

$339K raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

$500.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Aye, Belgium

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

$57.2M raised
Nov 2024

Founder Contacts

41,000+ verified contacts

New York, United States

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

$91.0M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Bold Health is a specialty telemedicine company that offers multi-disciplinary care for Gastrointestinal (GI) conditions.

$34K raised
Nov 2021

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.

$15.0M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Boston, United States

BAKX Therapeutics is a provider of cancer treatment.

$25.0M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Berlin, Germany

Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.

$23.2M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Allschwil, Switzerland

GlioCART is a University of Basel spin-out developing the first CAR-T cell therapy for glioblastoma (GBM), an aggressive brain cancer,

$188K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Belmont, United States

Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.

$120.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Waltham, United States

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

$125.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Resilience Lab is modernizing how clinicians work together to provide mental health care that’s high-quality, personalized, and accessible.

$15.0M raised
Nov 2022

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

$11.3M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Intact Therapeutics is a makers of smart gels for local drug delivery for gastrointestinal diseases.

Nov 2021

Founder Contacts

41,000+ verified contacts

Tempe, United States

CyMedica Orthopedics develops and commercializes products that target joint injuries and the resulting muscle atrophy.

$2.9M raised
Nov 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Serinus Biosciences develops technologies to understand how chemicals work inside malignant tumor cells.

$150K raised
Nov 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.

Nov 2021

Founder Contacts

41,000+ verified contacts

Waltham, United States

Mural Oncology is a protein engineering platform to reimagine cytokine-based immunotherapies for the treatment of cancer.

$275.0M raised
Nov 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

$107.0M raised
Nov 2022

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.

Nov 2021

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.

$9.5M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Showing 1526 to 1550 of 1,699 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,699 therapeutics companies tracked in the VCBacked database.

Average Funding
$57.3M
Total Funding Tracked
$1.4B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
3 companies$509.9M
2.New York
3 companies$106.2M
3.Boston
2 companies$132.0M
4.Waltham
2 companies$400.0M
5.Burlington
1 companies$42.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,699 Therapeutics Startups (2026) — Recently Funded — Page 62 | VCBacked